Harvard Bioscience (HBIO)

$5.27 -0.33 (-5.89%)
Market Cap 21.82M
Revenue (ttm) 86.55M
Net Income (ttm) -56.70M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -65.51%
Debt to Equity Ratio 2.41
Volume 63,100
Avg Vol 49,857
Day's Range N/A - N/A
Shares Out 4.47M
Stochastic %K 73%
Beta 1.51
Analysts Sell
Price Target $60.00

Company Profile

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States, Germany, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation a...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 508 893 8999
Fax: 508 429 5732
Address:
84 October Hill Road, Suite 10, Holliston, United States
mirage282828
mirage282828 Mar. 20 at 9:55 AM
$HBIO so my May 15th calls they're still the same are they going to get adjusted or not does anybody have any information
1 · Reply
FoxyDreams
FoxyDreams Mar. 20 at 2:33 AM
}{@SqueezeSharkie is on another level, outperforming 90% of traders on this platform. If you’re not following yet, you’re leaving value on the table. Takes 2 seconds and it’s free. 💎 $SLNG $INTZ $QTTB $HBIO ^^ on watch
0 · Reply
Nj126677
Nj126677 Mar. 19 at 11:36 PM
$HBIO
0 · Reply
Axen7
Axen7 Mar. 19 at 11:06 PM
$HBIO damn so quite in here after such a great day! Am I one of the only few left?! CEO just bought shares too :)
1 · Reply
topstockalerts
topstockalerts Mar. 19 at 5:35 PM
$HBIO thin and choppy, not the cleanest chart. Only gets interesting when volume spikes hit.
0 · Reply
Axen7
Axen7 Mar. 19 at 4:27 PM
$HBIO
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Mar. 18 at 12:00 AM
$HBIO CEO purchased 5,000 shares at $5.01 for a total of $25,050. Duke John D now owns 105,000 shares. https://ceo-buys.com
0 · Reply
Axen7
Axen7 Mar. 17 at 5:46 PM
$HBIO hope there is positive feedback today after the Healthcare forum
0 · Reply
TwongStocks
TwongStocks Mar. 16 at 8:15 PM
Today's reverse split results. Nine reverse splits on NASDAQ today. 7 of 9 closed green. Part 1 of 2 $CLIR 1 for 10 Previous close $0.4328, $4.328 split-adjusted Intraday high $4.75 Today's close $4.355 🟢Up 0.62% $DXST 1 for 25 Previous close $0.2290, $5.725 split-adjusted Intraday high $7.99 Today's close $6.60 🟢Up 15.28% $HBIO 1 for 10 Previous close $0.4735, $4.735 split-adjusted Intraday high $5.25 Today's close $5.01 🟢Up 5.81% $MASK.X 1 for 25 Previous close $0.1354, $3.385 split-adjusted Intraday high $3.92 Today's close $3.22 🔴Down 4.87% $NIVF 1 for 4 Previous close $0.5700, $2.28 split-adjusted Intraday high $2.43 Today's close $2.34 🟢Up 2.63% No splits scheduled on NASDAQ tomorrow.
0 · Reply
topstockalerts
topstockalerts Mar. 16 at 4:13 PM
$HBIO Not a bad session at all for momentum traders 🙌. Price moved cleanly higher. Buyers stayed in control.
1 · Reply
Latest News on HBIO
Harvard Bioscience, Inc. (HBIO) Q4 2025 Earnings Call Transcript

Mar 12, 2026, 10:02 AM EDT - 9 days ago

Harvard Bioscience, Inc. (HBIO) Q4 2025 Earnings Call Transcript

Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results

Mar 12, 2026, 7:30 AM EDT - 9 days ago

Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results

Harvard Bioscience Announces Reverse Stock Split

Mar 6, 2026, 4:01 PM EST - 15 days ago

Harvard Bioscience Announces Reverse Stock Split

Harvard Bioscience to Participate in KeyBanc's Virtual Healthcare Forum

Mar 3, 2026, 7:30 AM EST - 18 days ago

Harvard Bioscience to Participate in KeyBanc's Virtual Healthcare Forum

Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET

Feb 26, 2026, 7:30 AM EST - 23 days ago

Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET

Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas

Feb 10, 2026, 7:30 AM EST - 5 weeks ago

Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas

Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth

Jan 29, 2026, 4:30 PM EST - 7 weeks ago

Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth

Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package

Dec 17, 2025, 7:30 AM EST - 3 months ago

Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package

Harvard Bioscience, Inc. (HBIO) Q3 2025 Earnings Call Transcript

Nov 7, 2025, 2:16 AM EST - 4 months ago

Harvard Bioscience, Inc. (HBIO) Q3 2025 Earnings Call Transcript

Harvard Bioscience Announces Third Quarter 2025 Financial Results

Nov 6, 2025, 7:00 AM EST - 4 months ago

Harvard Bioscience Announces Third Quarter 2025 Financial Results

Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET

Oct 30, 2025, 8:00 AM EDT - 5 months ago

Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET

Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States

Sep 16, 2025, 7:00 AM EDT - 6 months ago

Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States

Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors

Sep 9, 2025, 7:00 AM EDT - 6 months ago

Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors

Harvard Bioscience, Inc. (HBIO) Q2 2025 Earnings Call Transcript

Aug 11, 2025, 9:54 AM EDT - 7 months ago

Harvard Bioscience, Inc. (HBIO) Q2 2025 Earnings Call Transcript

Harvard Bioscience Announces Second Quarter 2025 Financial Results

Aug 11, 2025, 7:00 AM EDT - 7 months ago

Harvard Bioscience Announces Second Quarter 2025 Financial Results

Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET

Aug 4, 2025, 4:30 PM EDT - 8 months ago

Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET

Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board

Jul 17, 2025, 7:00 AM EDT - 8 months ago

Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board

Harvard Bioscience Appoints John Duke to Board of Directors

Jun 2, 2025, 4:57 PM EDT - 10 months ago

Harvard Bioscience Appoints John Duke to Board of Directors

Harvard Bioscience, Inc. (HBIO) Q1 2025 Earnings Call Transcript

May 12, 2025, 12:41 PM EDT - 11 months ago

Harvard Bioscience, Inc. (HBIO) Q1 2025 Earnings Call Transcript

Harvard Bioscience Announces First Quarter 2025 Financial Results

May 12, 2025, 7:00 AM EDT - 11 months ago

Harvard Bioscience Announces First Quarter 2025 Financial Results

Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET

May 5, 2025, 4:45 PM EDT - 11 months ago

Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET

Harvard Bioscience Announces CFO Transition

Apr 10, 2025, 4:45 PM EDT - 1 year ago

Harvard Bioscience Announces CFO Transition

Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025

Mar 12, 2025, 4:00 PM EDT - 1 year ago

Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025

Harvard Bioscience, Inc. (HBIO) Q4 2024 Earnings Call Transcript

Mar 12, 2025, 11:19 AM EDT - 1 year ago

Harvard Bioscience, Inc. (HBIO) Q4 2024 Earnings Call Transcript

Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results

Mar 12, 2025, 7:21 AM EDT - 1 year ago

Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results

Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting

Feb 24, 2025, 4:45 PM EST - 1 year ago

Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting

Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET

Feb 24, 2025, 11:00 AM EST - 1 year ago

Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET

Harvard Bioscience, Inc. to Participate in the Sidoti Micro Cap Conference

Jan 13, 2025, 5:52 PM EST - 1 year ago

Harvard Bioscience, Inc. to Participate in the Sidoti Micro Cap Conference

Harvard Bioscience, Inc. (HBIO) Q3 2024 Earnings Call Transcript

Nov 9, 2024, 9:37 AM EST - 1 year ago

Harvard Bioscience, Inc. (HBIO) Q3 2024 Earnings Call Transcript

Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET

Oct 29, 2024, 5:00 PM EDT - 1 year ago

Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET

Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual Meeting

Sep 18, 2024, 7:30 AM EDT - 1 year ago

Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual Meeting

Harvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual Conference

Sep 5, 2024, 4:05 PM EDT - 1 year ago

Harvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual Conference

Harvard Bioscience, Inc. (HBIO) Q2 2024 Earnings Call Transcript

Aug 11, 2024, 7:09 AM EDT - 1 year ago

Harvard Bioscience, Inc. (HBIO) Q2 2024 Earnings Call Transcript

Harvard Bioscience Announces Second Quarter 2024 Financial Results

Aug 8, 2024, 8:30 AM EDT - 1 year ago

Harvard Bioscience Announces Second Quarter 2024 Financial Results

Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET

Aug 2, 2024, 8:00 AM EDT - 1 year ago

Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET

Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024

Jun 6, 2024, 4:05 PM EDT - 1 year ago

Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024

Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024

May 23, 2024, 4:05 PM EDT - 1 year ago

Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024

Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference

May 16, 2024, 4:05 PM EDT - 2 years ago

Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference

Harvard Bioscience, Inc. (HBIO) Q1 2024 Earnings Call Transcript

May 7, 2024, 12:52 PM EDT - 2 years ago

Harvard Bioscience, Inc. (HBIO) Q1 2024 Earnings Call Transcript

Harvard Bioscience Announces First Quarter 2024 Financial Results

May 7, 2024, 7:00 AM EDT - 2 years ago

Harvard Bioscience Announces First Quarter 2024 Financial Results

Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET

Apr 29, 2024, 8:45 AM EDT - 2 years ago

Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET

Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth

Apr 9, 2024, 9:00 AM EDT - 2 years ago

Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth

Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti's Small Cap Conference and KeyBanc's Life Sciences & MedTech Conference

Mar 11, 2024, 8:00 AM EDT - 2 years ago

Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti's Small Cap Conference and KeyBanc's Life Sciences & MedTech Conference

Harvard Bioscience, Inc. (HBIO) Q4 2023 Earnings Call Transcript

Mar 7, 2024, 9:56 AM EST - 2 years ago

Harvard Bioscience, Inc. (HBIO) Q4 2023 Earnings Call Transcript

Harvard Bioscience Announces Fourth Quarter 2023 Financial Results

Mar 7, 2024, 7:00 AM EST - 2 years ago

Harvard Bioscience Announces Fourth Quarter 2023 Financial Results

Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET

Feb 27, 2024, 5:10 PM EST - 2 years ago

Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET

Harvard Bioscience to Present at Benchmark Company's Discovery One-On-One Investor Conference on December 7, 2023

Nov 20, 2023, 4:40 PM EST - 2 years ago

Harvard Bioscience to Present at Benchmark Company's Discovery One-On-One Investor Conference on December 7, 2023

Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023

Nov 9, 2023, 4:30 PM EST - 2 years ago

Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023

Harvard Bioscience, Inc. (HBIO) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 2:08 PM EST - 2 years ago

Harvard Bioscience, Inc. (HBIO) Q3 2023 Earnings Call Transcript

Harvard Bioscience Announces Third Quarter 2023 Financial Results

Nov 7, 2023, 7:00 AM EST - 2 years ago

Harvard Bioscience Announces Third Quarter 2023 Financial Results

mirage282828
mirage282828 Mar. 20 at 9:55 AM
$HBIO so my May 15th calls they're still the same are they going to get adjusted or not does anybody have any information
1 · Reply
FoxyDreams
FoxyDreams Mar. 20 at 2:33 AM
}{@SqueezeSharkie is on another level, outperforming 90% of traders on this platform. If you’re not following yet, you’re leaving value on the table. Takes 2 seconds and it’s free. 💎 $SLNG $INTZ $QTTB $HBIO ^^ on watch
0 · Reply
Nj126677
Nj126677 Mar. 19 at 11:36 PM
$HBIO
0 · Reply
Axen7
Axen7 Mar. 19 at 11:06 PM
$HBIO damn so quite in here after such a great day! Am I one of the only few left?! CEO just bought shares too :)
1 · Reply
topstockalerts
topstockalerts Mar. 19 at 5:35 PM
$HBIO thin and choppy, not the cleanest chart. Only gets interesting when volume spikes hit.
0 · Reply
Axen7
Axen7 Mar. 19 at 4:27 PM
$HBIO
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Mar. 18 at 12:00 AM
$HBIO CEO purchased 5,000 shares at $5.01 for a total of $25,050. Duke John D now owns 105,000 shares. https://ceo-buys.com
0 · Reply
Axen7
Axen7 Mar. 17 at 5:46 PM
$HBIO hope there is positive feedback today after the Healthcare forum
0 · Reply
TwongStocks
TwongStocks Mar. 16 at 8:15 PM
Today's reverse split results. Nine reverse splits on NASDAQ today. 7 of 9 closed green. Part 1 of 2 $CLIR 1 for 10 Previous close $0.4328, $4.328 split-adjusted Intraday high $4.75 Today's close $4.355 🟢Up 0.62% $DXST 1 for 25 Previous close $0.2290, $5.725 split-adjusted Intraday high $7.99 Today's close $6.60 🟢Up 15.28% $HBIO 1 for 10 Previous close $0.4735, $4.735 split-adjusted Intraday high $5.25 Today's close $5.01 🟢Up 5.81% $MASK.X 1 for 25 Previous close $0.1354, $3.385 split-adjusted Intraday high $3.92 Today's close $3.22 🔴Down 4.87% $NIVF 1 for 4 Previous close $0.5700, $2.28 split-adjusted Intraday high $2.43 Today's close $2.34 🟢Up 2.63% No splits scheduled on NASDAQ tomorrow.
0 · Reply
topstockalerts
topstockalerts Mar. 16 at 4:13 PM
$HBIO Not a bad session at all for momentum traders 🙌. Price moved cleanly higher. Buyers stayed in control.
1 · Reply
chinchinbull
chinchinbull Mar. 16 at 3:41 PM
$ZSPC vs $WNW vs $HBIO vs $ULY
0 · Reply
erevnon
erevnon Mar. 16 at 2:57 PM
Benchmark maintains Harvard Bioscience $HBIO at Speculative Buy and raises the price target from $0.6 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
DARKP00L
DARKP00L Mar. 16 at 2:41 PM
$HBIO
0 · Reply
mirage282828
mirage282828 Mar. 16 at 2:05 PM
$HBIO so what's going to happen to my May 15th calls
1 · Reply
anachartanalyst
anachartanalyst Mar. 16 at 2:01 PM
$HBIO https://anachart.com/wp-content/uploads/ana_temp/1773669680_soc-img.jpg
0 · Reply
Axen7
Axen7 Mar. 16 at 2:01 PM
$HBIO alright a little green here!
0 · Reply
DARKP00L
DARKP00L Mar. 16 at 1:42 PM
$HBIO 09:26 on Mar. 16 2026 Benchmark Maintains Speculative Buy on Harvard Bioscience, Raises Price Target to $6 #tradeideas
0 · Reply
TwongStocks
TwongStocks Mar. 16 at 12:30 PM
$CLIR $DXST $HBIO $MASK.X $NIVF Nine NASDAQ stocks with reverse splits today. Trading scheduled to resume at 9:00am ET with the RS in effect. RS details in the quoted post.
0 · Reply
sentinelles
sentinelles Mar. 14 at 8:35 PM
$IVF The company has announced a 1-for-4 reverse stock split effective March 16, 2026. $MASK.X On March 11, 2026, the company announced a 25-for-1 share consolidation. This means every 25 old shares will be combined into 1 new share. $HBIO The stock is expected to begin trading on a split-adjusted basis on Monday, March 16, 2026.
2 · Reply
FreeBeerTomorrow
FreeBeerTomorrow Mar. 14 at 9:50 AM
$HBIO * Harvard Bioscience (HBIO) is scheduled to begin trading on a split-adjusted basis this coming Monday, March 16, 2026. Ratio: 1-for-10 . ​Estimated Public Float: ~3.57 million shares.
0 · Reply
TwongStocks
TwongStocks Mar. 13 at 8:05 PM
Nine(!!!) NASDAQ reverse splits scheduled on Monday. Expect trading to halt at 7:50pm ET tonight and resume at 9:00am ET Monday morning. Have to split this post into two parts. PART 1 $CLIR 1 for 10. Will reduce outstanding shares from approx 54.1m to approx 5.41m. $DXST 1 for 25. Will reduce outstanding shares from approx 40.38m to approx 1.62m. $HBIO 1 for 10. Will reduce outstanding shares from approx 44.72m to approx 4.47m. $MASK.X 1 for 25. Will reduce outstanding shares from approx 28.24m to approx 1.13m. $NIVF 1 for 4. Will reduce outstanding shares from approx 2.27m to approx 568k.
1 · Reply
anachartanalyst
anachartanalyst Mar. 13 at 2:01 PM
$HBIO https://anachart.com/wp-content/uploads/ana_temp/1773410495_soc-img.jpg
0 · Reply